Dr. Paul Hamlin, MD

Claim this profile

Memorial Sloan Kettering Cancer Center

Studies Lymphoma
Studies Non-Hodgkin's Lymphoma
2 reported clinical trials
6 drugs studied

Affiliated Hospitals

Image of trial facility.
Memorial Sloan Kettering Cancer Center

More about Paul Hamlin, MD

Clinical Trial Related7 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical Trials
Treatments Paul Hamlin, MD has experience with
  • Rituximab
  • Geriatric Assessment
  • Prednisone
  • Autologous Stem Cell Transplantation (ASCT)
  • Bendamustine
  • Melphalan

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul Hamlin, MD specialize in?
Paul Hamlin, MD focuses on Lymphoma and Non-Hodgkin's Lymphoma. In particular, much of their work with Lymphoma has involved treating patients, or patients who are undergoing treatment.
Is Paul Hamlin, MD currently recruiting for clinical trials?
No, Paul Hamlin, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Paul Hamlin, MD has studied deeply?
Yes, Paul Hamlin, MD has studied treatments such as Rituximab, Geriatric Assessment, Prednisone.
What is the best way to schedule an appointment with Paul Hamlin, MD?
Apply for one of the trials that Paul Hamlin, MD is conducting.
What is the office address of Paul Hamlin, MD?
The office of Paul Hamlin, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.